|Articles|September 15, 2002
- BioPharm International-09-01-2002
- Volume 15
- Issue 9
Retrovirus and Parvovirus Clearance from an Affinity Column Product Using Adsorptive Depth Filtration
by Barbara Tipton, Jeri Ann Boose, Joanne Beck, Thomas O'Brien, and William Larsen, CUNO Incorporated Two types of depth filters are studied for their ability to rid protein solutions of retroviruses and parvoviruses. Such filters are relatively economical and easy to use, so as secondary virus-removing devices, they are beneficial for downstream processing of mammalian cell cultures. Results indicate that depth filters are more effective on retroviruses than parvoviruses.
Advertisement
Articles in this issue
over 23 years ago
Reexamining the Set It and Forget It Approachover 23 years ago
Security in the Corporate Homelandover 23 years ago
Integrating New Technology into Blood Plasma Fractionationover 23 years ago
Attack Mounts on Pharmaceutical Pricesover 23 years ago
If a Tree Fell in the ForestNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5
